Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The goal of this study is to measure the safety, tolerability, and the hair growth response
to topical DLQ01 solutions in comparison to the vehicle and a comparator solution in 120
males with Androgenetic Alopecia.